Fábio Fiúza Rosa
1 – 17 of 17
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Article
-
Mark
Assessing efficacy and immune-stimulatory effects of tumor-derived dendritic cell reprogramming using immuno-competent 3D tumor spheroid model
2023) American Association for Cancer Research Annual Meeting 2023 In Cancer Research 83(7 Supplement).(
- Contribution to journal › Published meeting abstract
- 2022
-
Mark
Reprogramming primary melanoma cells to dendritic cell fate enhances tumor immunogenicity
2022) SITC Society for Immunotherapy of Cancer 2022(
- Contribution to conference › Poster
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Published meeting abstract
-
Mark
Direct Reprogramming of Mouse and Human Fibroblasts into Conventional Dendritic Cells Type 1
(
- Contribution to journal › Published meeting abstract
-
Mark
Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells
(
- Contribution to journal › Article
-
Mark
Eliciting Anti-Tumor Immunity by Reprogramming Cancer Cells to Type 1 Conventional Dendritic Cells
2022) European Association for Cancer Research 2022 - Congress(
- Contribution to conference › Poster
-
Mark
Harnessing Dendritic Cell Reprogramming to Elucidate Mechanisms of Tumor Immunity
2022) Lund Stem Cell Center Retreat(
- Contribution to conference › Poster
- 2021
-
Mark
Restoring the immunogenicity of cancer cells with dendritic cell reprogramming
(
- Contribution to journal › Published meeting abstract
-
Mark
GATA2 at the mitosis-to-G1 transition is critical for definitive hematopoiesis
2021) 2021 Virtual Annual Scientific Meeting of the ISEH - International Society for Experimental Hematology: ISEH 50th Annual Meeting In Experimental Hematology 100(Suppl). p.35-35(
- Contribution to journal › Published meeting abstract
-
Mark
Compositions for reprogramming into dendritic cells type 2 competent for antigen presentation, methods and uses thereof
2021) WO2021105234(
- Patent › Patent
-
Mark
Compositions for reprogramming cells into plasmacytoid dendritic cells or interferon producing cells, methods and uses thereof
2021) WO2021069672(
- Patent › Patent
-
Mark
Generating Dendritic Cells by Direct Cell Reprogramming. Merging cellular reprogramming with immunology towards the development of novel cancer immunotherapies.
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2020
-
Mark
Direct Reprogramming of Mouse Embryonic Fibroblasts to Conventional Type 1 Dendritic Cells by Enforced Expression of Transcription Factors
(
- Contribution to journal › Article
- 2019
-
Mark
Understanding and Modulating Immunity With Cell Reprogramming
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Direct reprogramming of fibroblasts into antigen-presenting dendritic cells
(
- Contribution to journal › Article
-
Mark
Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereof.
2018) WO2018185709A1(
- Patent › Patent